InnVentis is a pioneering brand that utilizes Big Data and Machine Learning to offer innovative solutions for both B2B and B2C markets in the field of diagnostics, monitoring, and therapeutic decision-making for major chronic inflammatory diseases. Our mission is to enable precision medicine by empowering patients, payers, and providers with real-time actionable insights. Chronic inflammation is a prevalent risk and contributor to numerous chronic diseases, such as arthritis, which is a leading cause of disability in the United States.

InnVentis addresses the key to successful treatment by focusing on precise diagnosis and treatment optimization. Our approach revolutionizes the market by providing proprietary molecular and real-world reference databases, cutting-edge algorithms, and a secure ICT architecture for real-time diagnostics, disease monitoring, and treatment decisions. We aim to fundamentally transform the development of drugs for inflammatory diseases and revolutionize treatment selection.

With our solutions, patients receive the right intervention and treatment from the moment of diagnosis. We also empower patients to actively monitor their personalized health and manage their diseases effectively. Embracing big data and integrating host genetics with longitudinal data, our understanding of inflammatory disease etiology will be significantly enhanced.

Join InnVentis in shaping the future of precision medicine and improving the lives of those affected by chronic inflammatory diseases